Form 4: Altimmune Executive Raymond Jordt Reports Stock Purchase Through Employee Stock Purchase Plan

Raymond Jordt, Chief Business Officer of Altimmune, Inc., reports the acquisition of 917 shares of common stock through the company's Employee Stock Purchase Plan (ESPP) at a price of $5.41 per share.

Summary

• Raymond Jordt, Chief Business Officer of Altimmune, acquired 917 shares of Altimmune, Inc. common stock on July 31, 2024.
• The purchase was made through the company's 2019 Employee Stock Purchase Plan (ESPP).
• The price per share was $5.41, representing 85% of the closing price on July 31, 2024.
• Following the transaction, Jordt directly owns 14,660 shares of Altimmune common stock.

Sentiment

Score: 6

Explanation: Neutral sentiment. The filing simply reflects a routine stock purchase through an employee stock purchase plan. It doesn't necessarily indicate strong positive or negative sentiment about the company's future.

Positives

• Executive participation in the ESPP demonstrates confidence in the company.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders (officers, directors, or those holding more than 10% of the company's shares) buy or sell the company's securities. These filings provide transparency into insider transactions and can be used by investors to gauge management's sentiment about the company's prospects.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals confidence from a company executive.

Key Dates